Header cover image

French (CAC) Biotech Industry Analysis

UpdatedJan 30, 2023
DataAggregated Company Financials
Companies36
  • 7D-1.7%
  • 3M2.3%
  • 1Y-41.0%
  • YTD0.8%

Over the last 7 days, the Biotech industry has dropped 1.7%, driven by Valneva declining 6.6%. In contrast, MaaT Pharma has gained 9.2%. Overall the industry is down 41% in 12 months. Looking forward, earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the French Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Jan 2023€3.7b€1.0b-€455,326,185.0012.1x-8.1x3.6x
Wed, 28 Dec 2022€3.4b€1.0b-€455,937,615.0011.9x-7.5x3.3x
Fri, 25 Nov 2022€3.5b€1.0b-€456,967,814.0012.8x-7.6x3.4x
Sun, 23 Oct 2022€3.7b€913.5m-€719,493,477.0016.4x-5.1x4x
Tue, 20 Sep 2022€3.9b€961.7m-€682,285,224.00117.1x-5.7x4x
Thu, 18 Aug 2022€4.7b€931.3m-€748,416,578.00120.9x-6.3x5.1x
Sat, 16 Jul 2022€4.3b€984.5m-€688,969,948.00120.7x-6.3x4.4x
Mon, 13 Jun 2022€4.5b€990.4m-€692,811,839.00130.5x-6.5x4.6x
Wed, 11 May 2022€4.3b€1.0b-€619,362,778.003.3x-6.9x4.2x
Fri, 08 Apr 2022€5.1b€1.2b-€576,047,272.0017.8x-8.9x4.4x
Sun, 06 Mar 2022€4.7b€950.3m-€656,955,632.0016.8x-7.1x4.9x
Tue, 01 Feb 2022€5.3b€932.4m-€678,848,688.002.8x-7.8x5.7x
Thu, 30 Dec 2021€7.1b€928.4m-€679,008,985.003.5x-10.5x7.7x
Sat, 27 Nov 2021€7.3b€925.7m-€680,558,540.003.6x-10.7x7.9x
Mon, 25 Oct 2021€7.0b€927.7m-€675,375,976.002.4x-10.3x7.5x
Wed, 22 Sep 2021€6.8b€893.6m-€620,510,282.002.7x-11x7.6x
Fri, 20 Aug 2021€6.4b€899.6m-€600,532,159.122.9x-10.6x7.1x
Fri, 04 Jun 2021€6.7b€882.0m-€570,006,611.923x-11.8x7.6x
Mon, 08 Mar 2021€7.2b€911.8m-€514,619,691.4222.8x-14x7.9x
Thu, 10 Dec 2020€5.8b€737.3m-€578,081,678.946.6x-10x7.8x
Wed, 02 Sep 2020€4.2b€624.3m-€569,407,653.4429.6x-7.4x6.8x
Sat, 06 Jun 2020€4.2b€608.4m-€585,561,414.9614.2x-7.2x6.9x
Tue, 10 Mar 2020€4.2b€548.6m-€625,688,103.6724.6x-6.7x7.7x
Price to Earnings Ratio

-7.1x


Total Market Cap: €4.4bTotal Earnings: -€625,688,103.67Total Revenue: €548.6mTotal Market Cap vs Earnings and Revenue0%0%0%
French Biotech Industry Price to Earnings3Y Average -8.8x202120222023
Current Industry PE
  • Investors are pessimistic on the French Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market1.41%
Healthcare-1.57%
Biotech-1.71%
Biotech-1.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MAAT MaaT Pharma€9.308.1%
+€7.0m
-21.2%PS85.5x
ALERS Eurobio Scientific Société anonyme€18.003.4%
+€6.5m
-15.1%PE4.2x
ALONX Onxeo€0.477.5%
+€3.6m
14.4%PS15x
IVA Inventiva€5.801.4%
+€3.4m
-46.2%PS25.1x
ALNFL NFL Biosciences€3.0617.7%
+€2.4m
61.9%n/a
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALONX

€0.47

Onxeo

7D

7.5%

1Y

14.4%

ALNOV

€0.85

Novacyt

7D

-19.5%

1Y

-57.4%

ALCLS

€2.91

Cellectis

7D

-8.2%

1Y

-48.5%

ALNFL

€3.06

NFL Biosciences

7D

17.7%

1Y

61.9%

ABNX

€1.89

ABIONYX Pharma

7D

-8.3%

1Y

-17.6%

IPH

€3.24

Innate Pharma

7D

-7.3%

1Y

-5.1%

ALACT

€7.60

Acticor Biotech SAS

7D

1.6%

1Y

29.3%

IVA

€5.80

Inventiva

7D

1.4%

1Y

-46.2%

DBV

€2.67

DBV Technologies

7D

-2.8%

1Y

-2.7%

VLA

€6.44

Valneva

7D

-7.1%

1Y

-57.9%

NANO

€3.63

Nanobiotix

7D

-3.1%

1Y

-47.8%

MAAT

€9.30

MaaT Pharma

7D

8.1%

1Y

-21.2%

GNRO

€1.41

GeNeuro

7D

6.4%

1Y

-61.4%

ERYP

€0.62

ERYTECH Pharma

7D

10.9%

1Y

-64.9%

ALERS

€18.00

Eurobio Scientific Société anonyme

7D

3.4%

1Y

-15.1%